PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ —  Concord Biosciences Holdings, Inc. (Nasdaq: HRMY), right this moment introduced that Concord (JO:)’s administration crew will take part within the following upcoming investor conferences:

Citi’s 2024 World Healthcare Convention

• Location:  Miami
• Tuesday, December 3, 2024

Piper Sandler 36^th Annual Healthcare Convention

• Location:  New York Metropolis
• Hearth Chat:  Wednesday, December 4, 2024, at  8:30 a.m., ET

A webcast of the hearth chat might be out there on the investor web page of Concord’s web site at https://ir.harmonybiosciences.com/.

About  Concord Biosciences
Concord Biosciences  is a pharmaceutical firm devoted to creating and commercializing revolutionary therapies for sufferers with uncommon neurological illnesses who’ve unmet medical wants. Pushed by novel science, visionary considering, and a dedication to those that really feel missed,  Concord Biosciences  is nurturing a future stuffed with therapeutic potentialities that will allow sufferers with uncommon neurological illnesses to actually thrive. Established by  Paragon Biosciences, LLC, in 2017 and headquartered in  Plymouth Assembly, PA, we imagine that when empathy and innovation meet, a greater future can start; a imaginative and prescient evident within the therapeutic improvements we advance, the tradition we domesticate, and the neighborhood packages we foster. For extra info, please go to  www.harmonybiosciences.com.

Concord Biosciences Investor Contact:
Brennan Doyle484-539-9700
bdoyle@harmonybiosciences.com

Concord Biosciences Media Contact:Cate McCanless202-641-6086
cmccanless@harmonybiosciences.com